Safety of hyperbaric oxygen therapy in patients with heart failure: A retrospective cohort study.

Simone Schiavo Connor T A BrennaLisa AlbertiniGeorge DjaianiAnton MarinovRita Katznelson

Published in: PloS one (2024)

Patients with HF, including HFpEF, may develop HF symptoms during HBOT and warrant ongoing surveillance. However, these patients can receive HBOT safely after optimization of HF therapy and fluid restriction.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
acute heart failure
chronic kidney disease
public health
prognostic factors
heart failure
patient reported outcomes
mesenchymal stem cells